Patent · US Active

Crystalline form of (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra-hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereof

US11814389B2 · kind B2 · utility

3Cited by

17References

8Claims

0Family size

Assignee

Beigene Switzerland GMBH · CH

Inventors

Zhiwei Wang · Beijing, CN
Yunhang Guo · Beijing, CN
Gongyin Shi · Beijing, CN

Key dates

Filing date	Jul 6, 2022
Grant date	Nov 14, 2023
Priority date	—
Expiry date	Jul 6, 2042

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02P20/55
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a crystalline form of (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra-hydropyrazolo[1,5-a]pyrimidine-3-carboxamide for inhibiting Btk, methods of preparation thereof and pharmaceutical compositions, and use of the crystalline form above in the treatment of a disease, or in the manufacturing of a medicament for the treatment of a disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.